BPharm


Also found in: Dictionary, Acronyms, Wikipedia.
Related to BPharm: PharmD, LBS, BfArM

Bachelor of Pharmacy

A university degree in the UK that was awarded after a 3-year undergraduate pharmacy program, which was superseded in 1997 by the Master of Pharmacy (MPharm), a degree awarded after a 4-year program through EU harmonisation.

BPharm

Abbrev. for Bachelor of Pharmacy.
References in periodicals archive ?
For example, the pharmacy program at Obafemi Awolowo University is run in the Faculty of Pharmacy and the core courses were Pharmaceutical Chemistry, Pharmacognosy, Pharmacology, and Pharmaceutics and awarded BPharm., whereas the counterpart at Ahmadu Bello University is Faculty of Pharmaceutical Sciences and the core courses were Pharmaceutical and Medicinal Chemistry, Pharmacognosy and Drug Development, Pharmacology and Therapeutics, and Pharmaceutics and Pharmaceutical Microbiology and awarded BSc.
Cindy Tworek, PhD, MPH [1,2] Pramit Nadpara, MS, BPharm [1] Bruce Adkins, MS, PA [3] Kimberly Horn, EdD [3,4] Geri Dino, PhD [3,4] Dan Christy, MPA [5] S.
Elizabeth Manias, PhD, RN, BPharm, MPharm, GradCertCritCare, MNursStud, is an Associate Professor at the School of Nursing, The University of Melbourne, Carlton, Australia.
Rhiannon Braund, BSc (Biochemistry), BPharm, RegPharmNZ, MPS
By Heather Boon, BScPhm, PhD & Michael Smith, BPharm, MRPharmS, ND
With an armful of degrees and qualifications - Bpharm, PhD, DSc, MRCP, Cbiol, FIBiol to name a few - Prof Caldwell is an internationally-renowned biomedical scientist.
Elizabeth Manias, PhD, RN, BPharm, MPharm, GradCertCritCare, MNursStud, is an Associate Professor and the Higher Degrees Coordinator at the School of Nursing, The University of Melbourne.
Professor Stephen Denyer BPharm, PhD(Nott), FRPharmS, (Head of School) will present:
Born 02/07/43 Corwen, Denbigh Spouse/ptnr Ann nee Evans Children Bryony and Hefin Educ Bala Boys Grammar School; Studied pharmacy at University of Wales, Cardiff; BPharm; MSc; Hon DSc.
C Tomlinson, (1) MA (Public Health); C Waterhouse, (2) MA (Human Rights Law); Y Q Hu, (2) PhD Law; S Meyer, (3) MSocSci (SW); H Moyo, (3) BPharm Hons
There are no therapies specifically approved for patients with HER2 expressing colorectal cancer, and continued study of fam- trastuzumab deruxtecan will provide a better understanding of the potential role of a HER2 targeting antibody drug conjugate in these patients, said Gilles Gallant, BPharm, PhD, Vice President, DS-8201 Global Team Leader, Oncology Research and Development, Daiichi Sankyo.